PCI Biotech Holding ASA (OSL:PCIB)

PCI Biotech Holding ASA Statistics

Total Valuation

OSL:PCIB has a market cap or net worth of NOK 10.49 million. The enterprise value is -2.85 million.

Market Cap	10.49M
Enterprise Value	-2.85M

Important Dates

The next estimated earnings date is Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	n/a

Share Statistics

OSL:PCIB has 37.33 million shares outstanding. The number of shares has increased by 1.07% in one year.

Current Share Class	37.33M
Shares Outstanding	37.33M
Shares Change (YoY)	+1.07%
Shares Change (QoQ)	-0.41%
Owned by Insiders (%)	9.13%
Owned by Institutions (%)	17.10%
Float	28.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.24
PB Ratio	0.84
P/TBV Ratio	0.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.14
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.17

Financial Position

The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.02.

Current Ratio	2.94
Quick Ratio	2.94
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-206.03

Financial Efficiency

Return on equity (ROE) is -92.47% and return on invested capital (ROIC) is -59.86%.

Return on Equity (ROE)	-92.47%
Return on Assets (ROA)	-48.34%
Return on Invested Capital (ROIC)	-59.86%
Return on Capital Employed (ROCE)	-172.86%
Revenue Per Employee	937,600
Profits Per Employee	-4.11M
Employee Count	5
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.64% in the last 52 weeks. The beta is 1.73, so OSL:PCIB's price volatility has been higher than the market average.

Beta (5Y)	1.73
52-Week Price Change	-84.64%
50-Day Moving Average	0.72
200-Day Moving Average	1.27
Relative Strength Index (RSI)	24.50
Average Volume (20 Days)	301,119

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:PCIB had revenue of NOK 4.69 million and -20.54 million in losses. Loss per share was -0.55.

Revenue	4.69M
Gross Profit	4.69M
Operating Income	-21.63M
Pretax Income	-20.54M
Net Income	-20.54M
EBITDA	-21.18M
EBIT	-21.63M
Loss Per Share	-0.55

Balance Sheet

The company has 13.62 million in cash and 282,000 in debt, giving a net cash position of 13.34 million or 0.36 per share.

Cash & Cash Equivalents	13.62M
Total Debt	282,000
Net Cash	13.34M
Net Cash Per Share	0.36
Equity (Book Value)	12.52M
Book Value Per Share	0.34
Working Capital	11.66M

Cash Flow

In the last 12 months, operating cash flow was -15.82 million and capital expenditures -631,000, giving a free cash flow of -16.45 million.

Operating Cash Flow	-15.82M
Capital Expenditures	-631,000
Free Cash Flow	-16.45M
FCF Per Share	-0.44

Margins

Gross Margin	100.00%
Operating Margin	-461.45%
Pretax Margin	-438.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OSL:PCIB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.07%
Shareholder Yield	n/a
Earnings Yield	-195.81%
FCF Yield	-156.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2